Xiao‐Ming Meng
Impact in
- Nephrology top 0.1%
- Chronic Kidney Disease and Diabetes
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Nephrology 51
- Chronic Kidney Disease and Diabetes 31
- Hepatology 39
- Liver physiology and pathology 38
- Co-authors
- Hui-Yao Lan (27 shared papers)David J. Nikolic‐Paterson (5 shared papers)Arthur C.K. Chung (8 shared papers)Jun Li (24 shared papers)Jun Li (60 shared papers)Xiao Ru Huang (9 shared papers)Taotao Ma (37 shared papers)Cheng Huang (53 shared papers)
- Journals
- International Immunopharmacology (17 papers)Frontiers in Pharmacology (13 papers)Toxicology and Applied Pharmacology (9 papers)Molecular Therapy (8 papers)European Journal of Pharmacology (7 papers)
- Partner nations
- ChinaHong KongSaint Kitts and Nevis
In The Last Decade
Xiao‐Ming Meng
268 papers receiving 16.7k citations
Xiao‐Ming Meng's Hit Papers
Peers
Comparison fields: 5 of 147
- Nephrology 3.0k
- Cancer Research 3.2k
- Hepatology 968
- Molecular Biology 7.7k
- Immunology 1.8k
Countries citing papers authored by Xiao‐Ming Meng
This map shows the geographic impact of Xiao‐Ming Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Ming Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Ming Meng more than expected).
Fields of papers citing papers by Xiao‐Ming Meng
This network shows the impact of papers produced by Xiao‐Ming Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Ming Meng. The network helps show where Xiao‐Ming Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao‐Ming Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 273 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TGF-β: the master regulator of fibrosis Hit paper breakdown → | 2016 | 2892 |
| 2 | Inflammatory processes in renal fibrosis Hit paper breakdown → | 2014 | 609 |
| 3 | TGF-β/Smad signaling in renal fibrosis Hit paper breakdown → | 2015 | 597 |
| 4 | 2011 | 511 | |
| 5 | 2011 | 373 | |
| 6 | 2013 | 333 | |
| 7 | 2010 | 328 | |
| 8 | 2013 | 324 | |
| 9 | 2012 | 318 | |
| 10 | 2010 | 307 | |
| 11 | 2016 | 272 | |
| 12 | 2012 | 254 | |
| 13 | Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms Hit paper breakdown → | 2022 | 238 |
| 14 | 2015 | 206 | |
| 15 | 2017 | 177 | |
| 16 | 2013 | 175 | |
| 17 | 2011 | 163 | |
| 18 | 2017 | 163 | |
| 19 | 2019 | 163 | |
| 20 | 2022 | 157 |
About Xiao‐Ming Meng
Xiao‐Ming Meng is a scholar working on Nephrology, Hepatology, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 273 papers that have together received 16.9k indexed citations. Recurring topics across this work include Liver physiology and pathology (38 papers), Liver Disease Diagnosis and Treatment (37 papers), Chronic Kidney Disease and Diabetes (31 papers), RNA modifications and cancer (24 papers), Renal and related cancers (24 papers), MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (21 papers) and TGF-β signaling in diseases (18 papers). The work is most often cited by research in Nephrology (3.0k citations), Cancer Research (3.2k citations), Hepatology (968 citations), Molecular Biology (7.7k citations) and Immunology (1.8k citations). Xiao‐Ming Meng has collaborated with scholars based in China, Hong Kong and Saint Kitts and Nevis. Frequent co-authors include Hui-Yao Lan, David J. Nikolic‐Paterson, Arthur C.K. Chung, Jun Li, Jun Li, Xiao Ru Huang, Taotao Ma, Cheng Huang, Haiyong Chen and Patrick Ming‐Kuen Tang. Their work appears in journals such as International Immunopharmacology, Frontiers in Pharmacology, Toxicology and Applied Pharmacology, Molecular Therapy and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.